Correspondence | Published:

Medical risks

Regulate devices for brain stimulation

Nature volume 533, page 179 (12 May 2016) | Download Citation

We are concerned that the rapid development and increased accessibility of non-invasive technologies with alleged brain-enhancing capabilities is allowing commercial interest to outpace regulatory mechanisms (see Nature 531, 283–284; 2016 and Nature 531, S6–S8; 2016).

Only limited technical ability is required to build a brain-stimulation device at home — or to dress it up and market it commercially. Even though electrical current can endanger cardiovascular and neural function (see, there are currently no requirements for safety or efficacy testing of home-use devices through clinical-style trials. Beyond the safety of the devices themselves, the impact of regular or sustained personal use of brain stimulators is unknown.

The public may not appreciate that companies are subject to a strict regulatory framework if their product claims to help an individual to achieve normal function (that is, a treatment), but not if it is sold to enhance function. We urge governments to align their regulatory standards for both applications.

Author information


  1. University of Melbourne, Australia.

    • Olivia Carter
    •  & Jason Forte


  1. Search for Olivia Carter in:

  2. Search for Jason Forte in:

Corresponding author

Correspondence to Olivia Carter.

About this article

Publication history



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing